These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16007194)

  • 1. E12 and E47 modulate cellular localization and proteasome-mediated degradation of MyoD and Id1.
    Lingbeck JM; Trausch-Azar JS; Ciechanover A; Schwartz AL
    Oncogene; 2005 Sep; 24(42):6376-84. PubMed ID: 16007194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo interactions of MyoD, Id1, and E2A proteins determined by acceptor photobleaching fluorescence resonance energy transfer.
    Lingbeck JM; Trausch-Azar JS; Ciechanover A; Schwartz AL
    FASEB J; 2008 Jun; 22(6):1694-701. PubMed ID: 18198216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin-Proteasome-mediated degradation of Id1 is modulated by MyoD.
    Trausch-Azar JS; Lingbeck J; Ciechanover A; Schwartz AL
    J Biol Chem; 2004 Jul; 279(31):32614-9. PubMed ID: 15163661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 1997 Jun; 36(22):6762-7. PubMed ID: 9184158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2A protein degradation by the ubiquitin-proteasome system is stage-dependent during muscle differentiation.
    Sun L; Trausch-Azar JS; Ciechanover A; Schwartz AL
    Oncogene; 2007 Jan; 26(3):441-8. PubMed ID: 16909127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-proteasome-mediated degradation, intracellular localization, and protein synthesis of MyoD and Id1 during muscle differentiation.
    Sun L; Trausch-Azar JS; Ciechanover A; Schwartz AL
    J Biol Chem; 2005 Jul; 280(28):26448-56. PubMed ID: 15888449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription.
    Lluís F; Ballestar E; Suelves M; Esteller M; Muñoz-Cánoves P
    EMBO J; 2005 Mar; 24(5):974-84. PubMed ID: 15719023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome.
    Berse M; Bounpheng M; Huang X; Christy B; Pollmann C; Dubiel W
    J Mol Biol; 2004 Oct; 343(2):361-70. PubMed ID: 15451666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel regulation of the helix-loop-helix protein Id1 by S5a, a subunit of the 26 S proteasome.
    Anand G; Yin X; Shahidi AK; Grove L; Prochownik EV
    J Biol Chem; 1997 Aug; 272(31):19140-51. PubMed ID: 9235903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins.
    Liu CJ; Ding B; Wang H; Lengyel P
    Mol Cell Biol; 2002 May; 22(9):2893-905. PubMed ID: 11940648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level expression and purification of MyoD, myogenin, and E12.
    Maleki SJ; Hurlburt BK
    Protein Expr Purif; 1997 Feb; 9(1):91-9. PubMed ID: 9116507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo.
    Lassar AB; Davis RL; Wright WE; Kadesch T; Murre C; Voronova A; Baltimore D; Weintraub H
    Cell; 1991 Jul; 66(2):305-15. PubMed ID: 1649701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the mUBC9-binding sites required for E2A protein degradation.
    Huggins GS; Chin MT; Sibinga NE; Lee SL; Haber E; Lee ME
    J Biol Chem; 1999 Oct; 274(40):28690-6. PubMed ID: 10497239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism.
    Sun L; Trausch-Azar JS; Muglia LJ; Schwartz AL
    Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3339-44. PubMed ID: 18296633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the inhibition of MyoD activity by ITF-2B and full-length E12/E47.
    Petropoulos H; Skerjanc IS
    J Biol Chem; 2000 Aug; 275(33):25095-101. PubMed ID: 10833525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cellular senescence and p16(INK4a) expression by Id1 and E47 proteins in human diploid fibroblast.
    Zheng W; Wang H; Xue L; Zhang Z; Tong T
    J Biol Chem; 2004 Jul; 279(30):31524-32. PubMed ID: 15138269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine (348) is a major determinant of the DNA binding specificity of transcription factor E12.
    Sieber M; Allemann RK
    Biol Chem; 1998 Jun; 379(6):731-5. PubMed ID: 9687024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and functional characterisation of avian transcription factor E2A.
    Conlon TM; Meyer KB
    BMC Immunol; 2004 Jun; 5():11. PubMed ID: 15196311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.